Home » Author Archive

Peel Hunt Reiterates Add Rating for Helical (LON:HLCL)

Helical (LON:HLCL)‘s stock had its “add” rating restated by research analysts at Peel Hunt in a research note issued to investors on Tuesday, ThisIsMoney.Co.Uk reports. Several other research firms also recently weighed in on HLCL. JPMorgan Chase & Co. decreased their price target on shares of Helical from GBX 475 ($5.85) to GBX 435 ($5.35) and set a “neutral” rating for the company in a research note on Thursday, April 30th. Berenberg Bank reissued a “buy” rating on shares of Helical in a research... 
 

Electrameccanica Vehicles (NASDAQ:SOLO) Cut to “Hold” at ValuEngine

Electrameccanica Vehicles (NASDAQ:SOLO) was downgraded by analysts at ValuEngine from a “buy” rating to a “hold” rating in a research note issued to investors on Tuesday, ValuEngine reports. A number of other research firms also recently commented on SOLO. Zacks Investment Research upgraded Electrameccanica Vehicles from a “hold” rating to a “buy” rating and set a $1.25 target price on the stock in a research report on Wednesday, April 1st. Aegis reissued a “buy” rating and issued a $4.00... 
 

Intermediate Capital Group (LON:ICP) PT Raised to GBX 1,716 at Canaccord Genuity

Intermediate Capital Group (LON:ICP) had its price target boosted by analysts at Canaccord Genuity from GBX 1,244 ($15.31) to GBX 1,716 ($21.12) in a report issued on Tuesday, Digital Look reports. The firm currently has a “buy” rating on the stock. Canaccord Genuity’s target price would indicate a potential upside of 32.51% from the company’s current price. A number of other analysts have also commented on the stock. Barclays upped their price objective on shares of Intermediate Capital Group from GBX 1,520 ($18.71) to... 
 

Zacks: Brokerages Expect PAR Technology Co. (NYSE:PAR) to Post -$0.32 EPS

Equities analysts expect PAR Technology Co. (NYSE:PAR) to announce ($0.32) earnings per share for the current quarter, according to Zacks Investment Research. Two analysts have provided estimates for PAR Technology’s earnings, with the lowest EPS estimate coming in at ($0.40) and the highest estimate coming in at ($0.23). PAR Technology reported earnings of ($0.18) per share during the same quarter last year, which would indicate a negative year over year growth rate of 77.8%. The firm is expected to announce its next quarterly earnings results... 
 

Zacks: Analysts Anticipate BIONDVAX PHARMA/S (NASDAQ:BVXV) Will Announce Earnings of -$0.01 Per Share

Brokerages expect BIONDVAX PHARMA/S (NASDAQ:BVXV) to report ($0.01) earnings per share for the current quarter, according to Zacks Investment Research. Zero analysts have issued estimates for BIONDVAX PHARMA/S’s earnings. BIONDVAX PHARMA/S posted earnings per share of ($2.02) in the same quarter last year, which indicates a positive year-over-year growth rate of 99.5%. The company is expected to issue its next earnings report on Wednesday, August 26th. On average, analysts expect that BIONDVAX PHARMA/S will report full year earnings of ($0.06)... 
 

DEUTSCHE BOERSE/ADR’s (DBOEY) Equal Weight Rating Reiterated at Morgan Stanley

DEUTSCHE BOERSE/ADR (OTCMKTS:DBOEY)‘s stock had its “equal weight” rating reiterated by research analysts at Morgan Stanley in a report released on Tuesday, The Fly reports. A number of other equities analysts also recently issued reports on the company. JPMorgan Chase & Co. reaffirmed an “overweight” rating on shares of DEUTSCHE BOERSE/ADR in a research report on Monday, June 8th. Royal Bank of Canada reaffirmed a “sector perform” rating on shares of DEUTSCHE BOERSE/ADR in a research report on Tuesday,... 
 

JPMorgan Chase & Co. Reiterates “Neutral” Rating for CRODA INTL PLC/ADR (OTCMKTS:COIHY)

CRODA INTL PLC/ADR (OTCMKTS:COIHY)‘s stock had its “neutral” rating restated by equities researchers at JPMorgan Chase & Co. in a report issued on Tuesday, The Fly reports. Other research analysts have also issued reports about the stock. Liberum Capital upgraded shares of CRODA INTL PLC/ADR from a “hold” rating to a “buy” rating in a research note on Tuesday, April 21st. Zacks Investment Research upgraded shares of CRODA INTL PLC/ADR from a “sell” rating to a “hold” rating in... 
 

CyrusOne (NASDAQ:CONE) Stock Rating Lowered by Zacks Investment Research

CyrusOne (NASDAQ:CONE) was downgraded by Zacks Investment Research from a “hold” rating to a “strong sell” rating in a research note issued to investors on Tuesday, Zacks.com reports. According to Zacks, “CyrusOne Inc. is a real estate investment trust engaged in providing enterprise data centre colocation, engineering facilities with the highest power redundancy (2N architecture) and power-density infrastructure services in the United States, Europe, and Asia. CyrusOne Inc. is headquartered in Carrollton, United States.... 
 

Contrasting ChampionX (NYSE:CHX) & Ecosphere Technologies (NYSE:ESPH)

ChampionX (NYSE:CHX) and Ecosphere Technologies (OTCMKTS:ESPH) are both construction companies, but which is the superior business? We will compare the two businesses based on the strength of their valuation, earnings, risk, analyst recommendations, dividends, institutional ownership and profitability. Valuation & Earnings This table compares ChampionX and Ecosphere Technologies’ revenue, earnings per share (EPS) and valuation. Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio ChampionX $1.13 billion 0.64 $52.16... 
 

Magnachip Semiconductor (NYSE:MX) Downgraded to “Strong Sell” at ValuEngine

Magnachip Semiconductor (NYSE:MX) was downgraded by investment analysts at ValuEngine from a “sell” rating to a “strong sell” rating in a report released on Tuesday, ValuEngine reports. Other equities research analysts have also recently issued reports about the company. Zacks Investment Research cut Magnachip Semiconductor from a “hold” rating to a “sell” rating in a research note on Wednesday, June 17th. Needham & Company LLC reiterated a “buy” rating and set a $18.00 target price... 
 

Comparing Cheesecake Factory (NASDAQ:CAKE) & Chuy’s (NASDAQ:CHUY)

Chuy’s (NASDAQ:CHUY) and Cheesecake Factory (NASDAQ:CAKE) are both small-cap retail/wholesale companies, but which is the better stock? We will compare the two companies based on the strength of their earnings, risk, valuation, profitability, institutional ownership, dividends and analyst recommendations. Analyst Ratings This is a summary of recent ratings and recommmendations for Chuy’s and Cheesecake Factory, as reported by MarketBeat. Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Chuy’s 0 6 3 0 2.33 Cheesecake... 
 

Intelsat (OTCMKTS:INTEQ) Lowered to “Hold” at ValuEngine

Intelsat (OTCMKTS:INTEQ) was downgraded by stock analysts at ValuEngine from a “buy” rating to a “hold” rating in a research note issued on Tuesday, ValuEngine reports. Separately, Zacks Investment Research downgraded shares of Intelsat from a “hold” rating to a “sell” rating in a report on Tuesday, June 16th. Shares of INTEQ stock opened at $0.42 on Tuesday. Intelsat has a 12 month low of $0.13 and a 12 month high of $27.29. The company has a market cap of $63.96 million, a PE ratio of -0.06 and a... 
 

Critical Review: CNFinance (CNF) and Its Rivals

CNFinance (NYSE: CNF) is one of 40 public companies in the “Nondepository credit institutions” industry, but how does it compare to its rivals? We will compare CNFinance to related companies based on the strength of its institutional ownership, earnings, valuation, analyst recommendations, profitability, dividends and risk. Profitability This table compares CNFinance and its rivals’ net margins, return on equity and return on assets. Net Margins Return on Equity Return on Assets CNFinance 12.28% 9.53% 2.46% CNFinance Competitors -2.01% -10.53% 1.60% Volatility... 
 

ValuEngine Lowers Mannatech (NASDAQ:MTEX) to Hold

Mannatech (NASDAQ:MTEX) was downgraded by analysts at ValuEngine from a “buy” rating to a “hold” rating in a research report issued to clients and investors on Tuesday, ValuEngine reports. Separately, TheStreet upgraded Mannatech from a “c” rating to a “b-” rating in a research report on Monday, June 15th. NASDAQ MTEX opened at $16.35 on Tuesday. The company has a quick ratio of 1.06, a current ratio of 1.44 and a debt-to-equity ratio of 0.01. The stock has a market cap of $38.03 million, a price-to-earnings... 
 

LTC Properties (NYSE:LTC) Stock Rating Upgraded by ValuEngine

LTC Properties (NYSE:LTC) was upgraded by investment analysts at ValuEngine from a “sell” rating to a “hold” rating in a research report issued on Tuesday, ValuEngine reports. LTC has been the topic of several other research reports. Wells Fargo & Co increased their target price on LTC Properties from $33.00 to $35.00 and gave the stock an “underweight” rating in a report on Friday, June 19th. Zacks Investment Research upgraded LTC Properties from a “sell” rating to a “hold” rating... 
 

Momo (NASDAQ:MOMO) Upgraded by ValuEngine to Hold

Momo (NASDAQ:MOMO) was upgraded by equities research analysts at ValuEngine from a “sell” rating to a “hold” rating in a research report issued to clients and investors on Tuesday, ValuEngine reports. Other research analysts have also issued research reports about the company. Zacks Investment Research raised Momo from a “sell” rating to a “hold” rating in a research report on Thursday, June 18th. JPMorgan Chase & Co. dropped their price target on Momo from $36.00 to $35.00 and set an “overweight”... 
 

Fresenius Medical Care AG & Co. KGaA (ETR:FME) PT Set at €84.00 by Goldman Sachs Group

Fresenius Medical Care AG & Co. KGaA (ETR:FME) received a €84.00 ($94.38) price objective from analysts at Goldman Sachs Group in a research note issued to investors on Tuesday, Borsen Zeitung reports. The brokerage presently has a “buy” rating on the stock. Goldman Sachs Group’s target price suggests a potential upside of 11.26% from the stock’s current price. Several other analysts have also recently issued reports on the company. Morgan Stanley set a €70.00 ($78.65) target price on Fresenius Medical Care... 
 

Contrasting Immunovant (IMVT) and Its Peers

Immunovant (NASDAQ: IMVT) is one of 143 public companies in the “Biological products, except diagnostic” industry, but how does it weigh in compared to its peers? We will compare Immunovant to similar companies based on the strength of its dividends, valuation, earnings, risk, institutional ownership, analyst recommendations and profitability. Profitability This table compares Immunovant and its peers’ net margins, return on equity and return on assets. Net Margins Return on Equity Return on Assets Immunovant N/A N/A N/A Immunovant... 
 

Financial Review: Palomar (NASDAQ:PLMR) vs. Chubb (NASDAQ:CB)

Chubb (NYSE:CB) and Palomar (NASDAQ:PLMR) are both finance companies, but which is the better business? We will compare the two companies based on the strength of their valuation, dividends, analyst recommendations, risk, earnings, profitability and institutional ownership. Earnings and Valuation This table compares Chubb and Palomar’s gross revenue, earnings per share and valuation. Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Chubb $35.31 billion 1.63 $4.45 billion $10.11 12.65 Palomar $113.30... 
 

Cloudflare (NYSE:NET) & Upland Software (NYSE:UPLD) Financial Analysis

Cloudflare (NYSE:NET) and Upland Software (NASDAQ:UPLD) are both computer and technology companies, but which is the superior stock? We will contrast the two companies based on the strength of their analyst recommendations, risk, earnings, profitability, dividends, valuation and institutional ownership. Analyst Ratings This is a summary of current recommendations for Cloudflare and Upland Software, as provided by MarketBeat. Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Cloudflare 0 5 9 0 2.64 Upland Software 0 0 6 0 3.00 Cloudflare... 
 

Contrasting Hewlett Packard Enterprise (NYSE:HPE) & KINGDEE INTL SO/ADR (NYSE:KGDEY)

KINGDEE INTL SO/ADR (OTCMKTS:KGDEY) and Hewlett Packard Enterprise (NYSE:HPE) are both computer and technology companies, but which is the superior investment? We will contrast the two companies based on the strength of their risk, dividends, earnings, profitability, valuation, institutional ownership and analyst recommendations. Earnings and Valuation This table compares KINGDEE INTL SO/ADR and Hewlett Packard Enterprise’s revenue, earnings per share and valuation. Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings... 
 

Mitsubishi Motors (OTCMKTS:MMTOF) Stock Rating Upgraded by Morgan Stanley

Mitsubishi Motors (OTCMKTS:MMTOF) was upgraded by stock analysts at Morgan Stanley from an “equal weight” rating to an “overweight” rating in a report released on Tuesday, The Fly reports. Shares of MMTOF stock opened at $2.54 on Tuesday. Mitsubishi Motors has a fifty-two week low of $2.40 and a fifty-two week high of $4.82. The stock’s 50-day simple moving average is $2.86 and its 200-day simple moving average is $3.27. An institutional investor recently bought a new position in Mitsubishi Motors stock. Fisher Asset... 
 

ELECTRICITE DE/ADR (OTCMKTS:ECIFY) Rating Increased to Hold at Zacks Investment Research

ELECTRICITE DE/ADR (OTCMKTS:ECIFY) was upgraded by Zacks Investment Research from a “sell” rating to a “hold” rating in a report released on Tuesday, Zacks.com reports. According to Zacks, “Electricite de France SA (EDF SA) is a France-based electricity producer, marketer and distributor. The company is largely owned by the French state and Nikhanj Electricite. They generate energy using nuclear technology, as well as thermal, hydroelectric and other renewable sources. It is involved in energy generation and energy... 
 

Electromed (NYSEAMERICAN:ELMD) Cut to “Sell” at Zacks Investment Research

Electromed (NYSEAMERICAN:ELMD) was downgraded by Zacks Investment Research from a “hold” rating to a “sell” rating in a report released on Tuesday, Zacks.com reports. According to Zacks, “Electromed, Inc. manufactures, markets and sells products that provide airway clearance therapy to patients with compromised pulmonary function. The Company is the designer, manufacturer and worldwide provider of the SmartVest┬« Airway Clearance System and related products. The patented system uses High Frequency Chest Wall Oscillation... 
 

Zacks Investment Research Downgrades Avid Bioservices (NASDAQ:CDMO) to Sell

Avid Bioservices (NASDAQ:CDMO) was downgraded by Zacks Investment Research from a “hold” rating to a “sell” rating in a report released on Tuesday, Zacks.com reports. According to Zacks, “Avid Bioservices, Inc. is a dedicated contract development and manufacturing organization focused on development and cGMP manufacturing of biopharmaceutical products derived from mammalian cell culture. The company provides process development, high quality cGMP clinical and commercial manufacturing services for the biotechnology... 
 

Reviewing Gold Reserve (OTCMKTS:GDRZF) and Maverix Metals (OTCMKTS:MMX)

Gold Reserve (OTCMKTS:GDRZF) and Maverix Metals (NYSE:MMX) are both small-cap basic materials companies, but which is the better investment? We will contrast the two businesses based on the strength of their risk, analyst recommendations, profitability, dividends, valuation, institutional ownership and earnings. Analyst Recommendations This is a summary of recent recommendations and price targets for Gold Reserve and Maverix Metals, as reported by MarketBeat. Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Gold Reserve 0 0 0 0 N/A Maverix... 
 

Marten Transport (NASDAQ:MRTN) Hits New 52-Week High on Analyst Upgrade

Marten Transport, Ltd (NASDAQ:MRTN) shares hit a new 52-week high during trading on Tuesday after KeyCorp raised their price target on the stock from $27.00 to $29.00. KeyCorp currently has an overweight rating on the stock. Marten Transport traded as high as $26.78 and last traded at $26.73, with a volume of 5029 shares changing hands. The stock had previously closed at $25.39. Other equities research analysts have also issued reports about the company. Loop Capital raised Marten Transport from a “hold” rating to a “buy”... 
 

Reviewing PING AN INS GRP/S (OTCMKTS:PNGAY) & HANNOVER RUECK/S (OTCMKTS:HVRRY)

PING AN INS GRP/S (OTCMKTS:PNGAY) and HANNOVER RUECK/S (OTCMKTS:HVRRY) are both large-cap finance companies, but which is the superior stock? We will compare the two businesses based on the strength of their analyst recommendations, institutional ownership, risk, valuation, profitability, dividends and earnings. Profitability This table compares PING AN INS GRP/S and HANNOVER RUECK/S’s net margins, return on equity and return on assets. Net Margins Return on Equity Return on Assets PING AN INS GRP/S N/A N/A N/A HANNOVER RUECK/S 5.75% 11.55% 1.82% Dividends PING... 
 

Contrasting Mainstreet Bank Common Stock (Virginia) (OTCMKTS:MNSB) and ANZ (OTCMKTS:ANZBY)

Mainstreet Bank Common Stock (Virginia) (OTCMKTS:MNSB) and ANZ (OTCMKTS:ANZBY) are both finance companies, but which is the superior investment? We will contrast the two companies based on the strength of their valuation, earnings, analyst recommendations, dividends, risk, profitability and institutional ownership. Analyst Ratings This is a summary of recent recommendations for Mainstreet Bank Common Stock (Virginia) and ANZ, as reported by MarketBeat.com. Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Mainstreet Bank... 
 

Financial Analysis: NantHealth (NASDAQ:NH) vs. Park City Group (NASDAQ:PCYG)

NantHealth (NASDAQ:NH) and Park City Group (NASDAQ:PCYG) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their institutional ownership, profitability, earnings, dividends, valuation, risk and analyst recommendations. Earnings & Valuation This table compares NantHealth and Park City Group’s top-line revenue, earnings per share and valuation. Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio NantHealth $95.96 million 6.91 -$62.76... 
 

Aldeyra Therapeutics (NASDAQ:ALDX) Receives New Coverage from Analysts at Oppenheimer

Oppenheimer initiated coverage on shares of Aldeyra Therapeutics (NASDAQ:ALDX) in a report issued on Tuesday, TipRanks reports. The brokerage set a “buy” rating and a $15.00 price target on the biotechnology company’s stock. Oppenheimer’s price objective indicates a potential upside of 244.04% from the stock’s previous close. Several other research analysts also recently issued reports on the stock. Laidlaw reiterated a “buy” rating and set a $30.00 price target on shares of Aldeyra Therapeutics in a research... 
 

Kering (EPA:KER) Earns “Buy” Rating from Goldman Sachs Group

Kering (EPA:KER)‘s stock had its “buy” rating restated by research analysts at Goldman Sachs Group in a report released on Tuesday, Borsen Zeitung reports. A number of other brokerages have also recently issued reports on KER. Deutsche Bank set a €455.00 ($511.24) target price on Kering and gave the stock a “neutral” rating in a report on Wednesday, April 22nd. Jefferies Financial Group set a €520.00 ($584.27) price target on Kering and gave the company a “neutral” rating in a research note on... 
 

Beiersdorf (ETR:BEI) PT Set at €102.00 by Independent Research

Beiersdorf (ETR:BEI) has been given a €102.00 ($114.61) price target by equities research analysts at Independent Research in a note issued to investors on Tuesday, Borsen Zeitung reports. The brokerage currently has a “neutral” rating on the stock. Independent Research’s price target points to a potential upside of 5.74% from the company’s current price. A number of other equities research analysts have also recently commented on the company. Nord/LB set a €84.00 ($94.38) price objective on Beiersdorf and gave... 
 

Alstom (EPA:ALO) PT Set at €38.00 by JPMorgan Chase & Co.

Alstom (EPA:ALO) has been assigned a €38.00 ($42.70) target price by stock analysts at JPMorgan Chase & Co. in a report released on Tuesday, Borsen Zeitung reports. The brokerage currently has a “neutral” rating on the stock. JPMorgan Chase & Co.‘s target price would suggest a potential downside of 10.44% from the stock’s current price. A number of other equities analysts have also weighed in on the stock. Kepler Capital Markets set a €42.50 ($47.75) price target on shares of Alstom and gave the stock... 
 

Pi Financial Analysts Give GT Gold (CVE:GTT) a C$2.60 Price Target

GT Gold (CVE:GTT) has been assigned a C$2.60 target price by stock analysts at Pi Financial in a note issued to investors on Tuesday, BayStreet.CA reports. The brokerage currently has a “buy” rating on the stock. Pi Financial’s price objective would suggest a potential upside of 41.30% from the stock’s previous close. Shares of CVE GTT opened at C$1.84 on Tuesday. The stock has a market cap of $251.45 million and a price-to-earnings ratio of -18.40. The business has a 50 day simple moving average of C$1.67 and a 200 day... 
 

Great Bear Resources (CVE:GBR) PT Raised to C$20.00

Great Bear Resources (CVE:GBR) had its price objective upped by equities research analysts at Cormark from C$16.50 to C$20.00 in a research report issued to clients and investors on Tuesday, BayStreet.CA reports. Cormark’s target price would suggest a potential upside of 8.11% from the stock’s current price. Several other brokerages also recently weighed in on GBR. Canaccord Genuity upped their target price on shares of Great Bear Resources from C$12.00 to C$15.25 in a research note on Monday, June 8th. Pi Financial set a C$15.25 price... 
 

Pi Financial Analysts Give Calibre Mining (CVE:CXB) a C$2.25 Price Target

Calibre Mining (CVE:CXB) has been given a C$2.25 price objective by stock analysts at Pi Financial in a report released on Tuesday, BayStreet.CA reports. The brokerage currently has a “buy” rating on the stock. CXB has been the subject of a number of other reports. Canaccord Genuity boosted their price objective on shares of Calibre Mining from C$2.25 to C$2.50 in a report on Wednesday, May 20th. Raymond James set a C$2.25 price objective on shares of Calibre Mining and gave the stock a “strong-buy” rating in a report on... 
 

Barclays Reiterates “Overweight” Rating for Man Wah (OTCMKTS:TKAYY)

Man Wah (OTCMKTS:TKAYY)‘s stock had its “overweight” rating reissued by equities research analysts at Barclays in a research report issued to clients and investors on Tuesday, The Fly reports. Other research analysts also recently issued research reports about the company. Morgan Stanley reissued an “overweight” rating on shares of Man Wah in a report on Thursday, July 2nd. HSBC downgraded Man Wah from a “buy” rating to a “hold” rating in a report on Thursday, June 11th. Goldman Sachs Group... 
 

Argonaut Gold (TSE:AR) PT Raised to C$4.50 at Laurentian

Argonaut Gold (TSE:AR) had its price objective upped by analysts at Laurentian from C$4.25 to C$4.50 in a report released on Tuesday, BayStreet.CA reports. Laurentian’s target price would indicate a potential upside of 71.10% from the stock’s previous close. Several other brokerages have also commented on AR. Canaccord Genuity lifted their price objective on Argonaut Gold from C$2.50 to C$3.25 in a report on Wednesday, May 20th. National Bank Financial lifted their price objective on Argonaut Gold from C$3.25 to C$3.50 and gave the... 
 

ZALANDO SE/ADR (OTCMKTS:ZLNDY) Stock Rating Reaffirmed by Barclays

ZALANDO SE/ADR (OTCMKTS:ZLNDY)‘s stock had its “overweight” rating restated by equities research analysts at Barclays in a note issued to investors on Tuesday, The Fly reports. Several other equities analysts have also recently issued reports on ZLNDY. Morgan Stanley reissued an “equal weight” rating on shares of ZALANDO SE/ADR in a report on Thursday, June 25th. Main First Bank raised ZALANDO SE/ADR from a “hold” rating to a “buy” rating in a report on Thursday, July 2nd. JPMorgan Chase &... 
 

Argonaut Gold (TSE:AR) PT Set at C$3.50 by National Bank Financial

Argonaut Gold (TSE:AR) has been assigned a C$3.50 price objective by stock analysts at National Bank Financial in a research note issued to investors on Tuesday, BayStreet.CA reports. The brokerage currently has an “outperform” rating on the mining company’s stock. National Bank Financial’s target price would suggest a potential upside of 33.08% from the stock’s current price. A number of other brokerages also recently commented on AR. Laurentian boosted their target price on shares of Argonaut Gold from C$4.25 to... 
 

Argonaut Gold (TSE:AR) PT Raised to C$4.50

Argonaut Gold (TSE:AR) had its price target upped by investment analysts at Laurentian Bank of Canada from C$4.25 to C$4.50 in a research note issued to investors on Tuesday, Stock Target Advisor reports. Laurentian Bank of Canada’s price objective suggests a potential upside of 71.10% from the stock’s previous close. A number of other research analysts have also recently commented on AR. Laurentian raised their price target on Argonaut Gold from C$4.25 to C$4.50 in a research report on Tuesday. National Bank Financial set a C$3.50... 
 

Zacks Investment Research Downgrades Exicure (OTCMKTS:XCUR) to Hold

Exicure (OTCMKTS:XCUR) was downgraded by Zacks Investment Research from a “buy” rating to a “hold” rating in a research report issued to clients and investors on Tuesday, Zacks.com reports. According to Zacks, “Exicure Inc. is a clinical-stage biotechnology company. It is engaged in developing therapeutics for immuno-oncology, inflammatory diseases and genetic disorders based on our proprietary Spherical Nucleic Acid technology. Exicure Inc. is based in IL, United States. “ A number of other research firms... 
 

KeyCorp Brokers Decrease Earnings Estimates for Dominion Energy Inc (NYSE:D)

Dominion Energy Inc (NYSE:D) – Equities research analysts at KeyCorp lowered their FY2024 earnings per share (EPS) estimates for shares of Dominion Energy in a report released on Monday, July 6th. KeyCorp analyst S. Karp now expects that the utilities provider will post earnings of $4.69 per share for the year, down from their prior forecast of $4.89. Other equities analysts have also recently issued research reports about the stock. Mizuho cut shares of Dominion Energy from a “neutral” rating to an “underperform”... 
 

Crossamerica Partners (NYSE:CAPL) Stock Rating Upgraded by Zacks Investment Research

Crossamerica Partners (NYSE:CAPL) was upgraded by Zacks Investment Research from a “sell” rating to a “hold” rating in a research note issued to investors on Tuesday, Zacks.com reports. According to Zacks, “CrossAmerica Partners LP engages in the wholesale distribution of motor fuels, consisting of gasoline and diesel fuel, and owns and leases real estate used in the retail distribution of motor fuels. CrossAmerica Partners LP, formerly known as Lehigh Gas Partners LP, is headquartered in Allentown, Pennsylvania. ... 
 

EDP Renovaveis (OTCMKTS:EDRVF) Stock Rating Upgraded by Berenberg Bank

EDP Renovaveis (OTCMKTS:EDRVF) was upgraded by stock analysts at Berenberg Bank from a “hold” rating to a “buy” rating in a research report issued on Tuesday, The Fly reports. Separately, Societe Generale upgraded EDP Renovaveis from a “hold” rating to a “buy” rating in a research report on Wednesday, May 27th. One equities research analyst has rated the stock with a hold rating and four have issued a buy rating to the stock. EDP Renovaveis presently has an average rating of “Buy”. EDP... 
 

Generation Bio (NASDAQ:GBIO) Research Coverage Started at Cowen

Investment analysts at Cowen initiated coverage on shares of Generation Bio (NASDAQ:GBIO) in a report issued on Tuesday, MarketBeat.com reports. The brokerage set an “outperform” rating on the stock. Separately, Jefferies Financial Group started coverage on Generation Bio in a research note on Tuesday. They issued a “buy” rating and a $38.00 price target for the company. Shares of GBIO stock opened at $19.75 on Tuesday. Generation Bio has a one year low of $18.51 and a one year high of $24.90. In other Generation Bio news,... 
 

Enerplus (NYSE:ERF) Shares Down 4.9% After Analyst Downgrade

Enerplus Corp (NYSE:ERF) (TSE:ERF) was down 4.9% during mid-day trading on Tuesday after CIBC lowered their price target on the stock from $5.00 to $4.50. CIBC currently has an outperform rating on the stock. Enerplus traded as low as $2.53 and last traded at $2.42, approximately 1,288,648 shares traded hands during trading. An increase of 2% from the average daily volume of 1,264,770 shares. The stock had previously closed at $2.54. ERF has been the topic of a number of other research reports. BMO Capital Markets dropped their price target on shares... 
 

The GEO Group (NYSE:GEO) Shares Gap Up After Dividend Announcement

The GEO Group Inc (NYSE:GEO) gapped up prior to trading on Tuesday following a dividend announcement from the company. The stock had previously closed at $10.97, but opened at $11.28. The GEO Group shares last traded at $11.28, with a volume of 1,987,500 shares traded. The newly announced dividend which will be paid on Friday, July 24th. Shareholders of record on Friday, July 17th will be paid a $0.48 dividend. This represents a $1.92 dividend on an annualized basis and a dividend yield of 16.42%. The ex-dividend date of this dividend is Thursday,... 
 

Imperial Oil Ltd (NYSEAMERICAN:IMO) Short Interest Update

Imperial Oil Ltd (NYSEAMERICAN:IMO) (TSE:IMO) was the target of a significant drop in short interest in June. As of June 30th, there was short interest totalling 13,630,000 shares, a drop of 9.0% from the June 15th total of 14,970,000 shares. Currently, 6.1% of the shares of the stock are sold short. Based on an average daily volume of 1,070,000 shares, the days-to-cover ratio is currently 12.7 days. A number of equities analysts have commented on IMO shares. Royal Bank of Canada boosted their price target on shares of Imperial Oil from $21.00... 
 
© 2006-2020 Zolmax.